StockData
PharmaCyte Biotech, Inc. logo

PharmaCyte Biotech, Inc. (PMCB) stock

PMCBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 6/30
$6.68−0.92 (-12.11%)

Close on Nov 13, 2026Market cap $71.71MP/E –Yield –

PharmaCyte Biotech price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

PharmaCyte Biotech's price to book ratio was 0.2× on Nov 11, 2026, against 0.1× a year earlier. Over the last 5 years it ranged from 0.1× to 0.7×, with a median of 0.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.2×+0.0
2025Dec 31, 20250.2×−0.1
2024Dec 31, 20240.3×−0.3
2023Dec 29, 20230.5×−0.2
2022Dec 30, 20220.7×+0.1
2021Dec 31, 20210.6×−1.4
2020Dec 31, 20202.0×−10.3
2019Dec 31, 201912.3×+4.6
2018Dec 31, 20187.7×+0.0
2017Dec 29, 20177.6×−13.2
2016Dec 30, 201620.8×+15.6
2015Dec 31, 20155.2×−15.1
2014Dec 31, 201420.3×+3.1
2013Dec 31, 201317.2×–

More PharmaCyte Biotech figures

See a number that looks wrong?